Texas lawsuit over drugs and vaccines provided by insurers ends with a win for the government — and HHS Secretary Robert F.

US regulators approved Moderna Inc.’s COVID-19 vaccine for children, but for a narrower group than before, continuing Robert ...

The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.

ASX health stocks fall o.92% over past five days as US President Donald Trump renews threat to impose tariffs on pharmaceutical imports.

Health Secretary Robert F. Kennedy Jr. looks poised to win the battle over fluoride, to the dismay of dentists and oral ...

Secretary Kennedy’s latest maneuver seeks to expand vaccine injury lawsuits, echoing a precarious time in US history when ...

The partnership will focus first on "enabling research around the root causes" of autism spectrum disorder (ASD), HHS said. Researchers can use the platform to identify autism diagnosis trends ...

In this week’s edition of InnovationRx, we look at Immuneering’s slow-and-steady approach to cancer fighting, litigation over ...

H2 2025 catalysts to watch, biopharma implications of President Trump’s tax law, KalVista’s new hereditary angioedema drug that Marty Makary reportedly tried to reject, another lawsuit aimed at Health ...

When Erez Kaminski set out to start his company, he wanted to make it the most boring software company anyone has ever built.

Kennedy, who spent years promoting debunked theories that vaccines aren’t safe, is systematically dismantling evidence-based ...

The S&P 500 ended Tuesday’s (July 8) session nearly unchanged, weighed down by continued uncertainty over President Donald ...